| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a383d5b36f62f0aa1f34b3b7549325c4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
| filingDate |
2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_730a559afc961244f311a3e9d96caaf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fcf17bbfead90b6b34e2aac0790ef18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96808e9dba91d6a845b0d57a990a57af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e9c29ed348c6e543b1660fdad103ab6 |
| publicationDate |
2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BG-104245-A |
| titleOfInvention |
PHARMACEUTICAL COMPOSITIONS CONTAINING PLASMA PROTEIN |
| abstract |
The invention relates to water-soluble products and pharmaceutical compositions in liquid and solid form, mainly for parenteral use. They are a therapeutically active (low solubility in water having a significant protein binding affinity) and a plasma protein fraction in a controlled aggregation state. The active substance and the plasma protein fraction are bound by non-covalent bonds. The invention also relates to methods for preparing the products and pharmaceutical compositions. |
| priorityDate |
1997-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |